,Bistability and oscillations in co-repressive synthetic microbial consortia

来源 :定量生物学(英文版) | 被引量 : 0次 | 上传用户:gaibian000000
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background:Synthetic microbial consortia are conglomerations of genetically engineered microbes programmed to cooperatively bring about population-level phenotypes.By coordinating their activity,the constituent strains can display emergent behaviors that are difficult to engineer into isogenic populations.To do so,strains are engineered to communicate with one another through intercellular signaling pathways that depend on cell density.Methods:Here,we used computational modeling to examine how the behavior of synthetic microbial consortia results from the interplay between population dynamics goveed by cell growth and inteal transcriptional dynamics goveed by cell-cell signaling.Specifically,we examined a synthetic microbial consortium in which two strains each produce signals that down-regulate transcription in the other.Within a single strain this regulatory topology is called a "co-repressive toggle switch" and can lead to bistability.Results:We found that in co-repressive synthetic microbial consortia the existence and stability of different states depend on population-level dynamics.As the two strains passively compete for space within the colony,their relative fractions fluctuate and thus alter the strengths of intercellular signals.These fluctuations drive the consortium to alteative equilibria.Additionally,if the growth rates of the strains depend on their transcriptional states,an additional feedback loop is created that can generate oscillations.Conclusions:Our findings demonstrate that the dynamics of microbial consortia cannot be predicted from their regulatory topologies alone,but are also determined by interactions between the strains.Therefore,when designing synthetic microbial consortia that use intercellular signaling,one must account for growth variations caused by the production of protein.
其他文献
The promise that big data will revolutionize scientific discovery and technology innovation is now being widely recognized.With the explosive growth of biomedic